Telos Capital Management’s Edwards Lifesciences EW Stock Holding History

Telos Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.49M	Buy	82,811 +396	+0.5%	+$33.2K	0.66%	51
2026 Q1	$6.6M	Buy	82,415 +4,700	+6%	+$387K	0.63%	65
2025 Q4	$6.63M	Buy	77,715 +5,630	+8%	+$462K	0.62%	60
2025 Q3	$5.61M	Buy	72,085 +9,670	+15%	+$756K	0.54%	72
2025 Q2	$4.88M	Buy	62,415 +7,156	+13%	+$534K	0.5%	76
2025 Q1	$4.01M	Buy	55,259 +3,665	+7%	+$262K	0.44%	80
2024 Q4	$3.82M	Sell	51,594 -47,300	-48%	-$3.31M	0.41%	80
2024 Q3	$6.53M	Buy	98,894 +1,519	+2%	+$110K	0.68%	56
2024 Q2	$8.99M	Buy	97,375 +2,045	+2%	+$181K	1%	33
2024 Q1	$9.11M	Buy	95,330 +3,925	+4%	+$330K	1.03%	33
2023 Q4	$6.97M	Buy	91,405 +56,000	+158%	+$3.9M	0.85%	38
2023 Q3	$2.45M	Buy	35,405 +4,555	+15%	+$366K	0.34%	79
2023 Q2	$2.91M	Buy	+30,850	New	+$2.68M	0.39%	74

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Telos Capital Management's EW Position: Q2 2026 in Review

Telos Capital Management increased its Edwards Lifesciences (EW) stake by 0.48% in Q2 2026, buying an estimated $33.2K and bringing the position to 82,811 shares worth $7.49M. The position accounts for 0.66% of the portfolio, ranked #51.

Telos Capital Management first reported a position in EW in Q2 2023 and has held it in 13 quarters since. The position peaked at $9.11M in Q1 2024. 414 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Telos Capital Management held 82,811 shares of Edwards Lifesciences worth $7.49M as of Q2 2026.
Telos Capital Management bought 396 Edwards Lifesciences shares in Q2 2026, an estimated $33.2K.
Edwards Lifesciences made up 0.66% of Telos Capital Management's portfolio in Q2 2026, its #51 holding.
Telos Capital Management first reported a position in Edwards Lifesciences in Q2 2023 and has held it in 13 quarters since.
Telos Capital Management's Edwards Lifesciences position peaked at $9.11M in Q1 2024.
414 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Telos Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.